The diagnosis of esophageal cancer by 2-deoxy-2-F-18 fluoro-D-glucose positron emission tomography (F-18 FDG PET)

被引：2

作者：

Alexander, Mohab ^{[1
]}

Brasic, James Robert ^{[1
]}

机构：

[1] Johns Hopkins Univ, Johns Hopkins Outpatient Ctr, Russell H Morgan Dept Radiol & Radiol Sci, Div Nucl Med,Sch Med, Baltimore, MD 21287 USA

来源：

CLINICAL NUCLEAR MEDICINE | 2006年 / 31卷 / 09期

关键词：

carcinoma; dysphagia; esophagus; malignancy; metastases; radiation therapy;

D O I：

10.1097/01.rlu.0000233350.01580.c2

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

FDG PET plays an essential role in the diagnosis and treatment of patients with esophageal carcinoma. A 67-year-old man, who presented with dysphagia, fatigue, weakness, anorexia, anergia, and weight loss, underwent Tc-99m bone scan, CT, and FDG PET imaging. The bone scan and CT were consistent with a malignancy. Whole-body FDG PET demonstrated multiple metastases in various locations and helped the treating physicians to institute appropriate therapy. The identification of metastases by FDG PET is a critical component of the initial evaluation of a patient with esophageal carcinoma for the diagnosis and treatment of the primary malignancy and metastases. Copyright © 2006 by Lippincott Williams & Wilkins.

引用

页码：566 / 567

页数：2

共 50 条

[1] 2-Deoxy-2-[F-18]Fluoro-d-Glucose–Positron Emission Tomography/Computed Tomography Imaging Evaluation of Esophageal Cancer
Hossein Jadvar
Robert W. Henderson
Peter S. Conti
[J]. Molecular Imaging and Biology, 2006, 8 : 193 - 200
[2] 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography/Computed Tomography in the Management of Melanoma
A. Iagaru
A. Quon
D. Johnson
S. S. Gambhir
I. R. McDougall
[J]. Molecular Imaging and Biology, 2007, 9
[3] 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma
Iagaru, A.
Quon, A.
Johnson, D.
Gambhir, S. S.
McDougall, I. R.
[J]. MOLECULAR IMAGING AND BIOLOGY, 2007, 9 (01) : 50 - 57
[4] 2-deoxy-2-(F-18)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology
Freebody, John
Wegner, Eva A.
Rossleigh, Monica A.
[J]. WORLD JOURNAL OF RADIOLOGY, 2014, 6 (10): : 741 - 755
[5] 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography-computed tomography in rheumatological diseases
Subesinghe, Manil
Bhuva, Shaheel
Arumalla, Nikita
Cope, Andrew
D'Cruz, David
Subesinghe, Sujith
[J]. RHEUMATOLOGY, 2022, 61 (05) : 1769 - 1782
[6] DIAGNOSIS OF PANCREATIC-CANCER BY 2[F-18]-FLUORO-2-DEOXY-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY
FRIESS, H
LANGHANS, J
EBERT, M
BEGER, HG
STOLLFUSS, J
RESKE, SN
BUCHLER, MW
[J]. GUT, 1995, 36 (05) : 771 - 777
[7] The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases
Hernández, GR
Avalos, CRDY
Delgado, JLC
[J]. MEDICINA CLINICA, 2005, 124 (06): : 229 - 236
[8] Ferret Thoracic Anatomy by 2-Deoxy-2-(18F)Fluoro-D-Glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Imaging
Wu, Albert
Zheng, Huaiyu
Kraenzle, Jennifer
Biller, Ashley
Vanover, Carol D.
Proctor, Mary
Sherwood, Leslie
Steffen, Marlene
Ng, Chin
Mollura, Daniel J.
Jonsson, Colleen B.
[J]. ILAR JOURNAL, 2012, 53 (01) : E9 - +
[9] Performance of 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography and Integrated PET/CT in Restaged Breast Cancer Patients
Barbara J. Fueger
Wolfgang A. Weber
Andrew Quon
Tyler L. Crawford
M. S. Allen-Auerbach
B. S. Halpern
Osman Ratib
Michael E. Phelps
Johannes Czernin
[J]. Molecular Imaging and Biology, 2005, 7 : 369 - 376
[10] Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients
Fueger, BJ
Weber, WA
Quon, A
Crawford, TL
Allen-Auerbach, MS
Halpern, BS
Ratib, O
Phelps, ME
Czernin, J
[J]. MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (05) : 369 - 376

← 1 2 3 4 5 →